CClinicalTrials.gg
CompletedNCT04675879Updated Feb 24, 2023

Clinical and Radiological Results of Conservative Treatments in Proximal Humerus Fractures.

An interventional study of Shoulder arm bandage in Proximal Humeral Fracture, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-24.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In the investigators' prospective randomized study, the investigator will investigate the effect of different bandage types on functional and radiological results of proximal humerus fractures over 18 years of age, for whom conservative treatment is decided.

In recent studies, it has been shown that surgical treatment in proximal humerus fractures has a high complication rate and is also not superior to conservative treatments in terms of functional results. Therefore, the importance of conservative treatment is increasing day by day in this group of fractures, especially in elderly patients with high risk for surgery.

In these studies in the literature, the method in conservative treatment is not clearly specified, and the investigator will apply 3 different bandages to adjust the rotation of the shoulder in 3 different ways during the investigators' conservative treatment. The investigator will compare functional and radiological results between these groups.

Read the detailed description

Proximal humerus fractures, who are admitted to the investigators' emergency department and are decided to follow conservative follow-up criteria, will be given one of 3 different bandages (velpau bandage, classical shoulder arm sling, 30 degree padded shoulder arm sling) according to the previous randomization.

Routinely, at the 2nd week, 6th week, 12th week, 6th month and 12th month outpatient clinic controls, the patients will be seen and their X-ray and clinical satisfaction status will be checked. X-rays will be taken as classical ap / lateral and true ap.

At the end of the second week, which is absolute immobilization, elbow and wrist movements will begin. Afterwards, in the 6th week, according to the state of union with deltoid strengthening, passive and active shoulder joint range of motion exercises will be started.

At the end of the 12th month, the follow-up will be terminated, and in this control, the existing joint movements will be recorded by measuring the degrees of anterior elevation, abduction, external rotation in neutral, external rotation at 90 degrees and internal rotation. In addition, in this control, the values will be noted by taking the Constant, ASES, DASH and VAS Scores.

After all these values are noted for all 3 groups, statistical analysis between groups will be made for each variable and the result will be given.

In addition, if complications(non-union,mal-union,stiffness etc.) occur during conservative follow-up in the investigators' patients, they will be recorded and whether there is a statistically significant difference in complications between the groups will be investigated.

The investigators' aim in this study is to understand whether any of these 3 different bandage types, which are routinely used as an immobilization method in proximal humerus fractures, are superior to the other.

A study comparing immobilization methods could not be found in the literature. These bandage types, which have not been compared with their effectiveness, are used effectively all over the world. With this study, the investigator set this on a scientific basis and set the correct direction of the investigators' treatments as the investigators' main goal.

02

Conditions studied

  • Proximal Humeral Fracture

Keywords

  • proximal humeral fractures
  • conservative treatments
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 120 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 345 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Neer type 2, 3 and 4 proximal humerus fractures suitable for conservative follow-up
  • Patients older than 18 years

Exclusion criteria

Exclusion Criteria:

  • Previous surgery in the ipsilateral shoulder area
  • Fractured dislocation
  • Patients with open phys line
  • Patients with neurological problems affecting the upper extremity (MS, stroke, etc.)
  • Patients with fracture-induced neurovascular problems
  • Open fractures
  • Patients who require surgery for any reason while follw-up (malunion, nonunion, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Investigator, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Velpau bandage (Group 1)

    Patients with neer type 2, 3 or 4 proximal humerus fractures under conservative follow-up with velpau bandage.

    Device: Shoulder arm bandage

  • Experimental
    Shoulder arm sling (Group 2)

    Patients with neer type 2, 3 or 4 proximal humerus fractures under conservative follow-up with shoulder arm sling.

    Device: Shoulder arm bandage

  • Experimental
    Padded shoulder arm sling (Group 3)

    Patients with neer type 2, 3 or 4 proximal humerus fractures under conservative follow-up with padded shoulder arm sling with 30 degree abduction.

    Device: Shoulder arm bandage

Interventions

  • DeviceShoulder arm bandage

    Three different shoulder-arm bandage types

06

What researchers measure

Primary outcomes

  1. External rotation degree

    degrees of external rotation achieved after conservative follow-up.

    Time frame: 12 months

Secondary outcomes

  1. Anterior elevation degree

    degrees of anterior elevation achieved after conservative follow-up.

    Time frame: 12 months

  2. Abduction degree

    degrees of abduction achieved after conservative follow-up.

    Time frame: 12 months

  3. Internal rotation degree

    degrees of internal rotation achieved after conservative follow-up.

    Time frame: 12 months

  4. DASH Score degree

    DASH score obtained at the end of follow-up of patients who completed 12 months of conservative follow-up. Minimum and maximum values are respectively 0 and 100. Higher scores mean a worse outcome.

    Time frame: 12 months

  5. Constant Score degree

    Constant score obtained at the end of follow-up of patients who completed 12 months of conservative follow-up Minimum and maximum values are respectively 8 and 100. Higher scores mean a better outcome.

    Time frame: 12 months

  6. ASES Score degree

    ASES score obtained at the end of follow-up of patients who completed 12 months of conservative follow-up Minimum and maximum values are respectively 0 and 100. Higher scores mean a better outcome.

    Time frame: 12 months

  7. VAS Score degree

    VAS score obtained at the end of follow-up of patients who completed 12 months of conservative follow-up Minimum and maximum values are respectively 0 and 10. Higher scores mean a worse outcome.

    Time frame: 12 months

07

Study locations

1 site
  • Bezmialem Vakıf University
    Istanbul, 34500, Turkey
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04675879
Lead sponsor
Bezmialem Vakif University
Responsible party
Murat Sarikas (Recident of orthopaedic surgery, Bezmialem Vakif University) — Principal investigator
First posted
Dec 19, 2020
Start date
Dec 1, 2020
Primary completion
Feb 23, 2023
Completion
Feb 23, 2023
Last update
Feb 24, 2023

Study contacts

Mehmet Kapıcıoğlu
study director · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion